Baird raised the firm’s price target on Icon (ICLR) to $224 from $222 and keeps an Outperform rating on the shares. The firm updated its model and sees a very favorable risk/rewar scenario.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- ICON plc Announces Participation in September 2025 Investor Conferences
- AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors
- ICON plc Releases Interim Financial Statements for 2025
- Icon downgraded to Neutral from Buy at Citi
- Icon’s Resilience and Growth Potential: Buy Rating Despite BARDA Trial Delays